GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of [Lab] ERP reta — PeptideMeter came back 98.9% against a claimed 98.0% — 61 comments in the full submission. View in context.
757
c/retatrutide·submitted 9 months ago by u/endotoxin_ellie

[Lab] ERP reta — PeptideMeter came back 98.9% against a claimed 98.0%

Labbranch of 6 comments

Short version of the title, which is already short: ERP reta — PeptideMeter came back 98.9% against a claimed 98.0%. Longer version underneath. Figures up front so nobody has to dig: 98.9% and 98.0%. Nothing containing this compound is approved anywhere. Research-use-only material is not approved for human use, and…

Read the full submission and all 61 comments →

This branch

6 comments, started 9 months ago
u/ledger_modMOD60 points·9 months ago

Removed the escalation schedule. There is no published protocol for members to follow and inventing one here is exactly what this board does not do.

replysharereportpermalink
u/kavya_kravchenko17 points·9 months ago

Disagree. "More receptors means more effect" is not how any of this works and the trial data does not support the linear story.

replysharereportpermalink
u/nikhil_lindqvist14 points·9 months ago

the glucagon component is why the metabolic story reads differently

replysharereportpermalink
[deleted]12 points·9 months ago

[deleted]

replysharereportpermalink
u/vito_beaulieu8 points·9 months ago·edited

heart rate is the thing people report watching

replysharereportpermalink
u/incretin_ivypharmacology-31 points·9 months ago

nothing here is available as a prescription product, so read every thread with that in mind

replysharereportpermalink

← back to the whole thread

About c/retatrutide

Retatrutide: GIP/GLP-1/glucagon triple agonism, the TRIUMPH programme, and the fact that most people discussing it are handling research-grade material with no human-use approval anywhere. Dose-response, heart-rate signal, and the unusually steep phase-2 weight curves get argued about here weekly.

65kmembers
130submissions
Sep 2023created
submissions / month, last year
Sponsored

PeptideMeter Analytics

Independent testing plus vendor-level trend data. Community-funded, unaffiliated.

peptidemeter.com
More in c/retatrutide
c/retatrutide rules
  1. Retatrutide is not approved anywhere for human use. Posts must not read as usage instructions.
  2. Phase 2 numbers are not maintenance numbers. Cite the trial and the dose arm.
  3. Heart-rate and dose-escalation reports need actual measurements, not impressions.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Full rules and how they are enforced →
Moderators
u/reta_and_regretu/trialwatch_theou/incretin_ivyu/ledger_mod
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.

Full disclaimer →